Q301--NEW - NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic)

Page 3 of 3

Sources Sought Notice

This notice is for planning purposes only and shall not be considered an invitation for bid, request for quotation, request for proposal, or as an obligation of the government to acquire any products or services. Responses to this notice will be used for informational purposes only. No entitlement to payment of direct or indirect costs from the government will arise as a result of a response to this announcement. No contract will be awarded from this notice.

The information requested in this notice will be used to determine if there are sufficient socioeconomic small business concerns that are capable of performing the work described for the requirement.

The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office (NCO) 17 is seeking sources for the following procurement:

Laboratory Testing Services: Contractor shall provide Reference Laboratory Testing Services to the VA, VA North Texas Healthcare System (NTX), in accordance with the attached Statement of Work (SOW).

BACKGROUND

VA North Texas Healthcare System

Pathology & Laboratory Medicine Services (P&LMS)

4500 S. Lancaster Rd.

Dallas, TX 75216

DESCRIPTION OF SERVICES

NTX requires reference laboratory testing of patient specimens that the facilities do not have the capacity or capability to perform on-site. A laboratory test is an examination, diagnostic, or monitoring procedure on a human specimen removed from the body to determine specific information for diagnosis, treatment, or prevention of disease, and to detect the impairment of health status, or to assess the health of human beings. Laboratory testing must be provided in compliance with the requirements in VHA Handbook 1106.01 and 42 CFR Part 493.

The contractor must hold and maintain a certificate of accreditation from the Centers for Medicare & Medicaid Services (CMS), as meeting the requirements of the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and must hold and maintain accreditation by the College of American Pathologists (CAP), or equivalent, to perform the services. See attached SOW for the performance requirements.

RESPONSE

If interested, vendors are to provide the following information in their response:

1. Name of Company

2. Point of Contact; name, phone number and email address

3. Contractor s Unique Entity ID (SAM)

4. Company socio-economic status (i.e., Small Business)

5. Capability Statement

6. Vendors expressing interest in participating in the requirement must complete and provide the attachment; Attachment A - Line Items, with the response.

Column E: Indicate if able to provide Testing

Column F: Indicate if testing is subcontracted

Column G: List Subcontractor Name (if applicable)

Column H: List the City and State where testing will be conducted

Column I: List the applicable CLIA number for the testing facility

If not applicable, please indicate with N/A.

7. Provide a copy of the CLIA certificate of accreditation for each laboratory listed in Column H of Attachment A. The certificate must include the Lab Certification Code(s) and effective date for the laboratory specialties and subspecialties the laboratory is certified to perform.

8. In addition, for each laboratory listed in the attachment, provide a declaration signed by the Laboratory Director listed on the CLIA Certificate of Accreditation that identifies which laboratory tests identified in the attachment are currently being performed at that laboratory.

Failure to provide the requested information for any test listed in Attachment A, or failure to provide the certificate of accreditation for any laboratory identified in the attachment will be considered by the VA to be a statement that the vendor responding to this notice is unable to provide that particular test.

The information provided in response to this notice may be used in developing an acquisition approach. Interested parties are responsible for adequately marking any proprietary or competitive sensitive information that is provided in a response.

Interested firms must respond to the notice to be considered. For any questions regarding this

notice email the Contracting Point of Contact no later than Friday, October 7, 2025, 10:00AM Central Time (11:00AM Eastern Time).